Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Stevanato Group S.P.A. (STVN)

Stevanato Group S.P.A. (STVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028 FinancialNewsMedia - Tue Sep 26, 2023

EQNX::TICKER_START (NASDAQ:STSS),(NYSE:STVN),(NYSE:WST),(NYSE:BDX),(NYSE:PFE) EQNX::TICKER_END

STSS : 0.2896 (-1.83%)
STVN : 19.60 (-0.96%)
WST : 284.76 (+2.74%)
BDX : 237.30 (+1.94%)
PFE : 30.77 (+3.39%)
Stevanato Group Reports First Quarter 2023 Financial Results Business Wire - Thu May 4, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced...

STVN : 19.60 (-0.96%)
Stevanato Group to Present at BofA Securities Healthcare Conference Business Wire - Tue May 2, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 19.60 (-0.96%)
Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023 Business Wire - Mon Apr 17, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 19.60 (-0.96%)
Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market Business Wire - Tue Mar 21, 2023

Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today its collaboration...

STVN : 19.60 (-0.96%)
Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products Business Wire - Thu Mar 16, 2023

Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced...

STVN : 19.60 (-0.96%)
Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum Business Wire - Tue Mar 14, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 19.60 (-0.96%)
Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global Growth Business Wire - Wed Mar 8, 2023

Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced two...

STVN : 19.60 (-0.96%)
Stevanato Group Reports Fourth Quarter and Fiscal Year 2022 Financial Results Business Wire - Thu Mar 2, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced...

STVN : 19.60 (-0.96%)
Stevanato Group to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 2, 2023 Business Wire - Thu Feb 16, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 19.60 (-0.96%)

Barchart Exclusives

Up 128% YTD, Should You Still Invest in Nvidia Stock? Barchart - Sat Jul 27, 10:45AM CDT
For investors looking to capitalize on a leader in the AI revolution, Nvidia remains a compelling opportunity with a promising outlook. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot